(D-Arg1,D-Pro2,D-Trp7·9,Leu11)-Substance P |
C75H108N20O13 |
1497.81 |
84676-91-5 |
H-D-Arg-D-Pro-Lys-Pro-Gln-Gln-D-Trp-Phe-D-Trp-Leu-Leu-NH2 |
(D-Arg1,D-Trp5·7·9,Leu11)-Substance P |
C81H110N20O12 |
1555.89 |
|
H-D-Arg-Pro-Lys-Pro-D-Trp-Gln-D-Trp-Phe-D-Trp-Leu-Leu-NH2 |
(D-Arg1,D-Trp7·9,Leu11)-Substance P, Spantide I |
C75H108N20O13 |
1497.81 |
91224-37-2 |
H-D-Arg-Pro-Lys-Pro-Gln-Gln-D-Trp-Phe-D-Trp-Leu-Leu-NH2 |
(D-Lys(nicotinoyl)1,β-(3-pyridyl)-Ala3,3,4-dichloro-D-Phe5,Asn6,D-Trp7,β-(3-pyridyl)-D-Ala9,Nle11)-Substance P, Spantide III |
C83H102Cl2N18O13 |
1630.74 |
154427-06-2 |
H-D-Lys(nicotinoyl)-Pro-β-(3-pyridyl)-Ala-Pro-3,4-dichloro-D-Phe-Asn-D-Trp-Phe-β-(3-pyridyl)-D-Ala-Leu-Nle-NH2 |
(D-Lys(nicotinoyl)1,β-(3-pyridyl)-Ala3,3,4-dichloro-D-Phe5,Asn6,D-Trp7·9,Nle11)-Substance P, Spantide II |
C86H104Cl2N18O13 |
1668.79 |
129176-97-2 |
H-D-Lys(nicotinoyl)-Pro-β-(3-pyridyl)-Ala-Pro-3,4-dichloro-D-Phe-Asn-D-Trp-Phe-D-Trp-Leu-Nle-NH2 |
(D-Pro2,D-Phe7,D-Trp9)-Substance P |
C72H105N19O13S |
1476.81 |
77275-70-8 |
H-Arg-D-Pro-Lys-Pro-Gln-Gln-D-Phe-Phe-D-Trp-Leu-Met-NH2 |
(D-Pro2,D-Trp7·9)-Substance P |
C74H106N20O13S |
1515.85 |
80434-86-2 |
H-Arg-D-Pro-Lys-Pro-Gln-Gln-D-Trp-Phe-D-Trp-Leu-Met-NH2 |
(D-Pro4,D-Trp7·9·10)-Substance P (4-11), Gpant-1, Ptt-SP (4-11) |
C62H74N14O10S |
1207.42 |
86917-57-9 |
H-D-Pro-Gln-Gln-D-Trp-Phe-D-Trp-D-Trp-Met-NH2 |
(D-Pro4,D-Trp7·9,Nle11)-Substance P (4-11) |
C58H77N13O10 |
1116.33 |
89430-34-2 |
H-D-Pro-Gln-Gln-D-Trp-Phe-D-Trp-Leu-Nle-NH2 |
(D-Pro4,D-Trp7·9·10,Val8)-Substance P (4-11), Pvt-SP (4-11) |
C58H74N14O10S |
1159.38 |
86917-56-8 |
H-D-Pro-Gln-Gln-D-Trp-Val-D-Trp-D-Trp-Met-NH2 |
(Arg6,D-Trp7·9,N-Me-Phe8)-Substance P (6-11) |
C49H66N12O6S |
951.21 |
115150-59-9 |
H-Arg-D-Trp-N-Me-Phe-D-Trp-Leu-Met-NH2 |
(Tyr6,D-Phe7,D-His9)-Substance P (6-11), Sendide |
C44H57N9O7S |
856.06 |
145194-26-9 |
H-Tyr-D-Phe-Phe-D-His-Leu-Met-NH2 |
Synaptobrevin-2 (73-79) (human, bovine, mouse, rat), Vesicle-Associated Membrane Protein 2 (73-79) (human, bovine, mouse, rat), VAMP-2 (73-79) (human, bovine, mouse, rat) |
C32H48N8O14 |
768.78 |
401933-00-4 |
H-Ala-Ser-Gln-Phe-Glu-Thr-Ser-OH |
Synaptobrevin-2 (75-78) (human, bovine, mouse, rat), Vesicle-Associated Membrane Protein 2 (75-78) (human, bovine, mouse, rat), VAMP-2 (75-78) (human, bovine, mouse, rat) |
C23H33N5O9 |
523.54 |
|
H-Gln-Phe-Glu-Thr-OH |
Syndyphalin SD-33 |
C25H34N4O5S |
502.63 |
87636-57-5 |
H-Tyr-D-Met(O)-Gly-N-Me-phenylethylamide |
Iberiotoxin |
C179H274N50O55S7 |
4230.91 |
129203-60-7 |
Pyr-Phe-Thr-Asp-Val-Asp-Cys-Ser-Val-Ser-Lys-Glu-Cys-Trp-Ser-Val-Cys-Lys-Asp-Leu-Phe-Gly-Val-Asp-Arg-Gly-Lys-Cys-Met-Gly-Lys-Lys-Cys-Arg-Cys-Tyr-Gln-OH (Disulfide bonds between Cys⁷ and Cys²⁸/Cys¹³ and Cys³³/Cys¹⁷ and Cys³⁵) |
Kaliotoxin |
C171H283N55O49S8 |
4150.01 |
145199-73-1 |
H-Gly-Val-Glu-Ile-Asn-Val-Lys-Cys-Ser-Gly-Ser-Pro-Gln-Cys-Leu-Lys-Pro-Cys-Lys-Asp-Ala-Gly-Met-Arg-Phe-Gly-Lys-Cys-Met-Asn-Arg-Lys-Cys-His-Cys-Thr-Pro-Lys-OH (Disulfide bonds between Cys⁸ and Cys²⁸/Cys¹⁴ and Cys³³/Cys¹⁸ and Cys³⁵) |
Margatoxin |
C178H286N52O50S7 |
4179.01 |
145808-47-5 |
H-Thr-Ile-Ile-Asn-Val-Lys-Cys-Thr-Ser-Pro-Lys-Gln-Cys-Leu-Pro-Pro-Cys-Lys-Ala-Gln-Phe-Gly-Gln-Ser-Ala-Gly-Ala-Lys-Cys-Met-Asn-Gly-Lys-Cys-Lys-Cys-Tyr-Pro-His-OH (Disulfide bonds between Cys⁷ and Cys²⁹/Cys¹³ and Cys³⁴/Cys¹⁷ and Cys³⁶) |
Noxiustoxin |
C174H286N52O54S7 |
4194.97 |
143074-44-6 |
H-Thr-Ile-Ile-Asn-Val-Lys-Cys-Thr-Ser-Pro-Lys-Gln-Cys-Ser-Lys-Pro-Cys-Lys-Glu-Leu-Tyr-Gly-Ser-Ser-Ala-Gly-Ala-Lys-Cys-Met-Asn-Gly-Lys-Cys-Lys-Cys-Tyr-Asn-Asn-NH2 (Disulfide bonds between Cys⁷ and Cys²⁹/Cys¹³ and Cys³⁴/Cys¹⁷ and Cys³⁶) |
Suc-Ala-Gln-Pro-Phe-pNA |
C32H39N7O10 |
681.7 |
128822-33-3 |
Suc-Ala-Gln-Pro-Phe-pNA |
Suc-Ala-Gly-Pro-Phe-pNA |
C29H34N6O9 |
610.62 |
128802-77-7 |
Suc-Ala-Gly-Pro-Phe-pNA |
Suc-Ala-His-Pro-Phe-pNA |
C33H38N8O9 |
690.71 |
128802-75-5 |
Suc-Ala-His-Pro-Phe-pNA |
Suc-Ala-Ile-Pro-Phe-pNA |
C33H42N6O9 |
666.73 |
128802-79-9 |
Suc-Ala-Ile-Pro-Phe-pNA |
Suc-Ala-Lys-Pro-Phe-pNA |
C33H43N7O9 |
681.75 |
128802-74-4 |
Suc-Ala-Lys-Pro-Phe-pNA |
Suc-Ala-Trp-Pro-Phe-pNA |
C38H41N7O9 |
739.79 |
128822-32-2 |
Suc-Ala-Trp-Pro-Phe-pNA |
Suc-Ala-Val-Pro-Phe-pNA |
C32H40N6O9 |
652.7 |
95192-38-4 |
Suc-Ala-Val-Pro-Phe-pNA |
T1, MSRPACPNDKYE |
C58H91N17O20S2 |
1410.6 |
207553-92-2 |
H-Met-Ser-Arg-Pro-Ala-Cys-Pro-Asn-Asp-Lys-Tyr-Glu-OH |
|
C20H30N6O4 |
418.5 |
37553-80-3 |
H-Phe-Pro-Arg-OH |
TFLLRamide, (Thr1)-TRAP-5 amide, (Thr1)-PAR-1 (1-5) amide (human) |
C31H53N9O6 |
647.82 |
197794-83-5 |
H-Thr-Phe-Leu-Leu-Arg-NH2 |
TRAP-5, Thrombin Receptor Activator Peptide 5, PAR-1 (1-5) (human), Proteinase Activated Receptor 1 (1-5) (human), Thrombin Receptor (1-5) (human), Coagulation Factor II Receptor (1-5) (human), SFLLR |
C30H50N8O7 |
634.78 |
141685-53-2 |
H-Ser-Phe-Leu-Leu-Arg-OH |
(Cit5)-TRAP-5, (Cit5)-Thrombin Receptor Activator Peptide 5, (Cit5)-PAR-1 (1-5) (human), (Cit5)-Proteinase Activated Receptor 1 (1-5) (human), (Cit5)-Thrombin Receptor (1-5) (human), (Cit5)-Coagulation Factor II Receptor (1-5) (human), SFLLCit |
C30H49N7O8 |
635.76 |
287184-84-3 |
H-Ser-Phe-Leu-Leu-Cit-OH |
TRAP-5 amide, Thrombin Receptor Activator Peptide 5 amide, SFLLRamide, PAR-1 (1-5) amide (human), Proteinase Activated Receptor 1 (1-5) amide (human), Thrombin Receptor (1-5) amide (human), Coagulation Factor II Receptor (1-5) amide (human) |
C30H51N9O6 |
633.79 |
141923-41-3 |
H-Ser-Phe-Leu-Leu-Arg-NH2 |
TRAP-6, Thrombin Receptor Activator Peptide 6, PAR-1 (1-6) (human), Proteinase Activated Receptor 1 (1-6) (human), Thrombin Receptor (1-6) (human), Coagulation Factor II Receptor (1-6) (human), SFLLRN |
C34H56N10O9 |
748.88 |
141136-83-6 |
H-Ser-Phe-Leu-Leu-Arg-Asn-OH |
TRAP-6 amide, Thrombin Receptor Activator Peptide 6 amide, PAR-1 (1-6) amide (human), Proteinase Activated Receptor 1 (1-6) amide (human), Thrombin Receptor (1-6) amide (human), Coagulation Factor II Receptor (1-6) amide (human), SFLLRNamide |
C34H57N11O8 |
747.9 |
141923-40-2 |
H-Ser-Phe-Leu-Leu-Arg-Asn-NH2 |
(DL-Isoser1)-TRAP-6, iso-TRAP, (DL-Isoser1)-Thrombin Receptor Activator Peptide 6, (DL-Isoser1)-PAR-1 (1-6) (human), (DL-Isoser1)-Proteinase Activated Receptor 1 (1-6) (human), (DL-Isoser1)-Thrombin Receptor 1 (1-6) (human) |
C34H56N10O9 |
748.88 |
150242-29-8 |
H-DL-Isoser-Phe-Leu-Leu-Arg-Asn-OH |
(Phe1,Ser2)-TRAP-6, (Phe1,Ser2)-Thrombin Receptor Activator Peptide 6, (Phe1,Ser2)-PAR-1 (1-6) (human), (Phe1,Ser2)-Proteinase Activated Receptor 1 (1-6) (human), (Phe1,Ser2)-Thrombin Receptor 1 (1-6) (human), (Phe1,Ser2)-Coagulation Factor II Receptor (1-6) (human), FSLLRN |
C34H56N10O9 |
748.88 |
374898-11-0 |
H-Phe-Ser-Leu-Leu-Arg-Asn-OH |
TRAP-6 (2-6), Thrombin Receptor Activator Peptide 6 (2-6), PAR-1 (2-6) (human), Proteinase Activated Receptor 1 (2-6) (human), Thrombin Receptor (2-6) (human), Coagulation Factor II Receptor (2-6) (human), FLLRN |
C31H51N9O7 |
661.8 |
141136-84-7 |
H-Phe-Leu-Leu-Arg-Asn-OH |
TRAP-7, Thrombin Receptor Activator Peptide 7, PAR-1 (1-7) (human), Proteinase Activated Receptor 1 (1-7) (human), Thrombin Receptor (1-7) (human), Coagulation Factor II Receptor (1-7) (human), SFLLRNP |
C39H63N11O10 |
846.01 |
145229-76-1 |
H-Ser-Phe-Leu-Leu-Arg-Asn-Pro-OH |
(Tyr1)-TRAP-7, YFLLRNP, (Tyr1)-Thrombin Receptor Activator Peptide 7, (Tyr1)-PAR-1 (1-7) (human), (Tyr1)-Proteinase Activated Receptor 1 (1-7) (human), (Tyr1)-Thrombin Receptor (1-7) (human), (Tyr1)-Coagulation Factor II Receptor (1-7) (human) |
C45H67N11O10 |
922.1 |
149440-16-4 |
H-Tyr-Phe-Leu-Leu-Arg-Asn-Pro-OH |
TRAP-14, Thrombin Receptor Activator Peptide 14, PAR-1 (1-14) (human), Proteinase Activated Receptor 1 (1-14) (human), Thrombin Receptor (1-14) (human), Coagulation Factor II Receptor (1-14) (human), SFLLRNPNDKYEPF |
C81H118N20O23 |
1739.95 |
137339-65-2 |
H-Ser-Phe-Leu-Leu-Arg-Asn-Pro-Asn-Asp-Lys-Tyr-Glu-Pro-Phe-OH |
TRAP-14 amide, Thrombin Receptor Activator Peptide 14 amide, Proteinase Activated Receptor 1 (1-14) amide (human), PAR-1 (1-14) amide (human), Thrombin Receptor (1-14) amide (human), Coagulation Factor II Receptor (1-14) amide (human), SFLLRNPNDKYEPFamide |
C81H119N21O22 |
1738.96 |
141923-36-6 |
H-Ser-Phe-Leu-Leu-Arg-Asn-Pro-Asn-Asp-Lys-Tyr-Glu-Pro-Phe-NH2 |
Hirullin |
C68H96N14O29 |
1573.59 |
131147-81-4 |
H-Ser-Asp-Phe-Glu-Glu-Phe-Ser-Leu-Asp-Asp-Ile-Glu-Gln-OH |
|
C31H45N7O7 |
627.74 |
65147-04-8 |
Boc-Val-Pro-Arg-AMC |
|
C37H43N7O6 |
681.79 |
88899-22-3 |
Bz-Phe-Val-Arg-AMC |
|
C20H30N8O5 |
462.51 |
77695-30-8 |
Sar-Pro-Arg-pNA |
Thrombin B-Chain (147-158) (human) |
C54H84N16O18 |
1245.36 |
207553-42-2 |
H-Thr-Trp-Thr-Ala-Asn-Val-Gly-Lys-Gly-Gln-Pro-Ser-OH |
|
C28H33N7O7 |
579.57 |
102601-58-1 |
Z-Gly-Gly-Arg-AMC |
|
C29H34N6O6 |
562.59 |
70375-23-4 |
Z-Pro-Arg-AMC |
H-Ile-Arg-Val-Val-Met-OH |
C27H52N8O6S |
616.83 |
149234-05-9 |
H-Ile-Arg-Val-Val-Met-OH |
H-Leu-Ser-Lys-Leu-OH |
C21H41N5O6 |
459.59 |
162559-45-7 |
H-Leu-Ser-Lys-Leu-OH |